TARGETED LIPOSOMES FOR siRNA DELIVERY TO CANCER.

CONCLUSION: siRNA delivery mediated by functionalized liposomes is promising, but clinical trials need to be conducted. PMID: 30084323 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30084323?dopt=Abstract

Source: Current Pharmaceutical Design - August 7, 2018 Category: Drugs & Pharmacology Authors: Eloy JO, Petrilli R, Raspantini GL, Lee RJ Tags: Curr Pharm Des Source Type: research